cd39 ax700 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
94
Structured Review
R&D Systems
cd39 ax700
Cd39 Ax700, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alexa+fluor+700/Human+CD39%2FENTPD1+Alexa+Fluor%C2%AE+700-conjugated+Antibody/pm42822324-60-35-37
Average 94 stars, based on 1 article reviews
Cd39 Ax700, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alexa+fluor+700/Human+CD39%2FENTPD1+Alexa+Fluor%C2%AE+700-conjugated+Antibody/pm42822324-60-35-37
Average 94 stars, based on 1 article reviews
cd39 ax700 - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
other:Article Title: Insights into the metastatic bone marrow niche gained from fibronectin and β1 integrin transgenic mice Article Snippet: CD114 , Alexa Fluor 700 , Marker:Article Title: The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model Article Snippet: Fc sites were blocked on the cells with purified anti-mouse CD16/32 Ab (catalog no. 101302; BioLegend). .. Cells were treated with the following Abs to cell surface marker panel: CD3ε–FITC (catalog no. 100306; BioLegend), CD19–PE (catalog no. 115508; BioLegend), CD4–allophycocyanin (catalog no. 100412; BioLegend), and their isotype control Abs FITC (catalog no. 400905; BioLegend), PE (catalog no. 400507; BioLegend), allophycocyanin (catalog no. 400611; BioLegend), and Control:Article Title: The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model Article Snippet: Fc sites were blocked on the cells with purified anti-mouse CD16/32 Ab (catalog no. 101302; BioLegend). .. Cells were treated with the following Abs to cell surface marker panel: CD3ε–FITC (catalog no. 100306; BioLegend), CD19–PE (catalog no. 115508; BioLegend), CD4–allophycocyanin (catalog no. 100412; BioLegend), and their isotype control Abs FITC (catalog no. 400905; BioLegend), PE (catalog no. 400507; BioLegend), allophycocyanin (catalog no. 400611; BioLegend), and Virus:Article Title: Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies. Article Snippet: Article Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies Recombinant:Article Title: Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies. Article Snippet: Article Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies Protease Inhibitor:Article Title: Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies. Article Snippet: Article Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies Proximity Ligation Assay:Article Title: Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies. Article Snippet: Article Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies Proliferation Assay:Article Title: Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies. Article Snippet: Article Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies Isolation:Article Title: Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies. Article Snippet: Article Bro1 proteins determine tumor immune evasion and metastasis by controlling secretion or degradation of multivesicular bodies |